Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
WORK Medical Chartwell Med Healthcare Investment
CompanyDeals

WORK Medical and Chartwell Med Partner on Investment Tools for Healthcare Projects

March 3, 2025
Innovent Biologics Doses First Patient in IBI363 Melanoma Study vs Keytruda
CompanyDrug

Innovent Biologics Doses First Patient in IBI363 Melanoma Study vs Keytruda

March 3, 2025
Eyebright Medtech Plans Private Placement to Expand Contact Lens Production
DealsDrug

Eyebright Medtech Plans Private Placement to Expand Contact Lens Production

March 3, 2025
Sinocelltech's Finotonlimab Gets NMPA Approval for Liver Cancer Treatment
CompanyDrug

Sinocelltech’s Finotonlimab Gets NMPA Approval for Liver Cancer Treatment

March 3, 2025
Danatlas Raises RMB 150M to Advance Synthetic Lethality Drug Pipeline
CompanyDeals

Danatlas Raises RMB 150M to Advance Synthetic Lethality Drug Pipeline

March 3, 2025
Magnet Biomedicine and Eli Lilly Partner on Molecular Glue Therapeutics
CompanyDeals

Magnet Biomedicine and Eli Lilly Partner on Molecular Glue Therapeutics

March 3, 2025
AstraZeneca and Amgen's Tezspire Shows Positive Results in Phase III Study
CompanyDrug

AstraZeneca and Amgen’s Tezspire Shows Positive Results in Phase III Study

March 3, 2025
Baidu Health Partners with Jolly Pharma to Boost Digital Drug Marketing
CompanyDeals

Baidu Health Partners with Jolly Pharma to Boost Digital Drug Marketing

March 3, 2025
Duality Biotherapeutics Updates IPO Filing with HKSE under Chapter 18A Rules
CompanyDeals

Duality Biotherapeutics Updates IPO Filing with HKSE under Chapter 18A Rules

March 3, 2025
CARsgen's CT041 Awarded Breakthrough Therapy Designation for Gastric Cancer
CompanyDrug

CARsgen’s CT041 Awarded Breakthrough Therapy Designation for Gastric Cancer

March 3, 2025
Huge Dental Files for Hong Kong IPO with Diverse Dental Product Portfolio
CompanyDeals

Huge Dental Files for Hong Kong IPO with Diverse Dental Product Portfolio

March 3, 2025
CSPC Pharmaceutical's Sirolimus Receives BTD for Malignant PEComa Treatment
Drug

CSPC Pharmaceutical’s Sirolimus Receives BTD for Malignant PEComa Treatment

March 3, 2025
1 2 … 29 30 31 32
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up